Main > > >NEUROTROPHIC KERATITIS. *

Ophthalmo.>TREAT.: Cenegermin Eye Drops.
Recombinant Human Nerve Growth Factor.
EU Approval Date : 2017. 07.06.
USA Approval Date: 2018. 08.22.
(*) Company; Patents & TradeMark Avai-
lable on Request.
UpDate: 2018. 08.27.




>NEUROTROPHIC KERATITIS. *'s products
This section has no products